Development of a five-year mortality model in systemic sclerosis patients by different analytical approaches

Clinical and Experimental Rheumatology

Volumn 28, Issue 2 SUPPL. 58, 2010, Pages

  Beretta, Lorenzo ^a   Santaniello, Alessandro ^a   Cappiello, Francesco ^a   Chawla, Nitesh V ^b   Vonk, Madelon C ^d   Carreira, Patricia E ^d   Allanore, Yannick ^e   Popa Diaconu, Delia A ^c   Cossu, Marta ^a   Bertolotti, Francesco ^a   Ferraccioli, Gianfranco ^f   Mazzone, Antonino ^g   Scorza, Raffaella ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b University of Notre Dame   (United States)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f CATHOLIC UNIVERSITY   (Italy)

^g Ospedali Civili di Legnano   (Italy)

Author keywords

Cox regression; Data mining; Na ve bayes; Survival; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; CENTROMERE ANTIBODY; SCL 70 ANTIBODY;

ACCURACY; ADULT; ANEMIA; ARTHRALGIA; ARTHRITIS; ARTICLE; CLASSIFIER; DIGITAL ULCER; FEMALE; HUMAN; INTERNAL VALIDITY; ITALY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RANDOM FOREST; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SURVIVAL; SYSTEMIC SCLEROSIS; ULCER; WEAKNESS; DATA MINING; DIFFUSE SCLERODERMA; EVALUATION; LIMITED SCLERODERMA; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL; SURVIVAL RATE;

ADULT; DATA MINING; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; ROC CURVE; SCLERODERMA, DIFFUSE; SCLERODERMA, LIMITED; SURVIVAL RATE;

EID: 77956630525     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. VILLAVERDE-HUESO A, SÁNCHEZ-VALLE E, ALVAREZ E et al.: Estimating the burden of scleroderma disease in Spain. J Rheumatol 2007; 34: 2236-42.
2. BRYAN C, HOWARD Y, BRENNAN P, BLACK C, SILMAN A: Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Br J Rheumatol 1996; 35: 1122-6.
3. MENDOZA F, DERK CT: Systemic sclerosis mortality in the United States: 1999-2002 implications for patient care. J Clin Rheumatol 2007; 13: 187-92.
4. KRISHNAN E, FURST DE: Systemic sclerosis mortality in the United States: 1979-1998. Eur J Epidemiol 2005; 20: 855-61.
5. FERRI C, VALENTINI G, COZZI F et al; Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SlR-GSSSc). Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002; 81: 139-53.
6. IOANNIDIS JP, VLACHOYIANNOPOULOS PG, HAIDICH AB et al.: Mortality in systemic sclerosis: an international meta-analysis of individual patient data Am J Med 2005; 118: 2-10.
7. MAYES MD, LACEY JV JR, BEEBE-DIMMER J et al.: Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003; 48: 2246-55.
8. SIMEÓN CP, ARMADANS L, FONOLLOSA V et al.: Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology (Oxford) 2003; 42: 71-5.
9. ALTMAN RD, MEDSGER TA JR, BLOCH DA, MICHEL BA: Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 1991; 34: 403-13.
10. SCUSSEL-LONZETTI L, JOYAL F, RAYNAULD JP et al.: Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 2002; 81: 154-67.
11. CZIRJÁK L, KUMÁNOVICS G, VARJÚ C et al.: Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 2008; 67: 59-63.
12. STEEN VD, MEDSGER TA: Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007; 66: 940-4.
13. BRYAN C, KNIGHT C, BLACK CM, SILMAN AJ: Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum 1999; 42: 2660-5.
14. HESSELSTRAND R, SCHEJA A, AKESSON A: Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998; 57: 682-6.
15. JACOBSEN S, HALBERG P, ULLMAN S: Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 1998; 37: 750-5.
16. KARASSA FB, IOANNIDIS JP: Mortality in systemic sclerosis. Clin Exp Rheumatol 2008; 26 (Suppl. 51): S85-93.
17. COX DR, OAKES D: Analysis of survival data. London: Chapman and Hall, 1984.
18. BATH PA: Data mining in health and medical information. In CRONIN B (Ed.) Annual Review of Information Science and Technology (ARIST) 2004; 38: 331-68.
19. FISHER LD, LIN DY: Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health 1999; 20: 145-57.
20. OHNO-MACHADO L: A comparison of Cox proportional hazards and artificial neural network models for medical prognosis. Comput Biol Med 1997; 27: 55-65.
21. BAKKER B, HESKES T, NEIJT J, KAPPEN B: Improving Cox survival analysis with a neural-Bayesian approach. Stat Med 2004; 23: 2989-3012.
22. BAKKER SJ: Crippling of inflammatory markers as predictors of death by dichotomization and multicollinearity. Nephrol Dial Transplant 2006; 21: 2990-1.
23. FAYYAD U, PIATETSKY-SHAPIRO G, SMYTH P: From Data Mining to Knowledge Discovery in Databases (a survey). AI Magazine Fall 1996; 17: 37-54.
24. BERETTA L, CAPPIELLO F, MOORE JH, SCORZA R: IL-1 Gene Complex Single Nucleotide Polymorphisms in Systemic Sclerosis: a Further Step Ahead. Human Immunol 2008; 69: 187-92.
25. LAVRAC N: Selected techniques for data mining in medicine. Artif Intell Med 1999; 16: 3-23.
26. JONSDOTTIR T, HVANNBERG ET, SIGURDSSON H, SIGURDSSON S: The feasibility of constructing a Predictive Outcome Model for breast cancer using the tool of data mining. Expert Systems with Applications 2008; 34: 108-118.
27. DELEN D, WALKER G, KADAM A: Predicting breast cancer survivability: a comparison of three data mining methods. Artif Intell Med 2005; 34: 113-27.
28. BLANCO R, INZA I, MERINO M, QUIROGA J, LARRAÑAGA P: Feature selection in Bayesian classifiers for the prognosis of survival of cirrhotic patients treated with TIPS. Biomed Inform 2005; 38: 376-88.
29. RAMON J, FIERENS D, GÜIZA F et al.: Mining data from intensive care patients. Advanced Engineering Informatics 2007; 21: 243-56.
30. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutics Criteria Committee. Arthritis Rheum 1980; 23: 581-90.
31. HUDSON M, TAILLEFER S, STEELE R et al.: Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis. Clin Exp Rheumatol 2007; 25: 754-7.
32. LEROY EC, BLACK C, FLEISCHMAJER R et al.: Scleroderma (systemic sclerosis): classification, subset and pathogenesis. J Rheumatol 1988; 15: 202-5.
33. WHITE B, BAUER EA, GOLDSMITH LA, HOCHBERG MC, KATZ LM, KORN JH: Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatlogy Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis. Sem Arthritis Rheum 1995; 38: 351-60.
34. STEEN VD, GRAHAM G, CONTE C, OWENS G, MEDSGER TA JR: Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum 1992; 35: 765-70.
35. MUKERJEE D, ST GEORGE D, KNIGHT C et al.: Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford) 2004; 43: 461-6.
36. KORN JH, MAYES M, MATUCCI CERINIC M et al.: Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 2004; 50: 3985-93.
37. VUK M, CURK T: ROC curve, Lift Chart and Calibration Plot. Metodološki Zvezki 2006; 3: 89-108.
38. BERETTA L, CAPPIELLO F, MOORE JH, BARILI M GREENE CS, SCORZA R: Epistatic interactions of cytokine single nucleotide polymorphisms predict susceptibility to disease subsets in systemic sclerosis patients. Arthritis Rheum 2008; 59: 974-83.
39. KONONENKO I: Inductive and bayesian learning in medical diagnosis. Appl Artif Intell 1993; 7: 317-37.
40. SAEYS Y, INZA I, LARRAÑAGA P: A review of feature selection techniques in bioinformatics. Bioinformatics 2007; 23: 2507-17.
41. MOŽINA, M, DEMŠAR J, KATTAN M, ZUPAN B: 2004. Nomograms for visualization of naive Bayesian classifier. In PROCEEDINGS OF THE 8TH EUROPEAN CONFERENCE ON PRINCIPLES AND PRACTICE OF KNOWLEDGE DISCOVERY IN DATABASES (Pisa, Italy, September 20-24, 2004).
42. BOULICAUT J, ESPOSITO F, GIANNOTTI F, PEDRESCHI D (Eds.) Lecture Notes In Computer Science, vol. 3202. Springer-Verlag New York, New York, NY, 337-48.
43. CHAWLA, NV, JAPKOWICZ N, KOTCZ A: Editorial: special issue on learning from imbalanced data sets. SIGKDD Explor Newsl 2004; 6: 1-6.
44. CHAWLA NV, BOWYER KW, HALL LO, KEGELMEYER WP. SMOTE: Synthetic Minority Over-sampling Technique. J Artif Intell Res 2002; 16: 321-357.
45. CHAWLA NV, CIESLAK DA, HALL LO, JOSHI AJ: Automatically countering imbalance and its empirical relationship to cost. Data Mining and Knowledge Discovery Journal 2008 Feb 17; [Epub ahead of print]. DOI 10.1007/S10618-008- 0087-0.
46. BATISTA GEAPA, PRATI RC, MONARD MC: A study of the behaviour of several methods for balancing machine learning training data. SIGKDD Explorations 2004; 6: 20-9.
47. VELEZ DR, WHITE BC, MOTSINGER AA et al.: A balanced accuracy function for epistasis modeling in imbalanced datasets using multifactor dimensionality reduction. Genet Epidemiol 2007; 31: 306-15.
48. KOHAVI R: A study of cross-validation and bootstrap for accuracy estimation and model selection. In Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, 1137-43. San Mateo, CA: Morgan Kaufmann, 1995.
49. RAZAVI AR, GILL H, ÅHLFELDT H, SHAHSAVAR N: Predicting metastasis in breast cancer: comparing a decision tree with domain experts. J Med Syst 200; 31: 263-73.
50. CONCATO J, FEINSTEIN AR, HOLFORD TR: The risk of determining risk with multi-variable models. Ann Intern Med 1993; 118: 201-10.
51. WEEKS JC, COOK EF, O'DAY SJ et al.: Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 1998; 279: 1709-14.
52. DEGNER LF, KRISTJANSON LJ, BOWMAN D et al.: Information needs and decisional preferences in women with breast cancer. JAMA 1997; 277: 1485-92.
53. ALLANORE Y, KAHAN A: Treatment of systemic sclerosis. Joint Bone Spine 2006; 73: 363-8.